The inflammation present in acute respiratory distress syndrome (ARDS) and thereby associated injury to the alveolar-capillary membrane and pulmonary surfactant can potentiate respiratory failure. Even considering the high mortality rate of severe ARDS, glucocorticoids appear to be a reasonable treatment option along with an appropriate route of delivery to the distal lung. This study aimed to investigate the effect of budesonide therapy delivered intratracheally by high-frequency oscillatory ventilation (HFOV) on lung function and inflammation in severe ARDS. Adult New Zealand rabbits with respiratory failure (P/F<13.3 kPa) induced by intratracheal instillation of hydrochloric acid (HCl, 3 ml/kg, pH 1.5) followed by high tidal ventilation (VT 20 ml/kg) to mimic ventilator-induced lung injury (VILI) were treated with intratracheal bolus of budesonide (0.25 mg/kg, Pulmicort) delivered by HFOV (frequency 8 Hz, MAP 1 kPa, deltaP 0.9 kPa). Saline instead of HCl without VILI with HFOV delivered air bolus instead of therapy served as healthy control. All animals were subjected to lung-protective ventilation for 4 h, and respiratory parameters were monitored regularly. Postmortem, lung injury, wet-to-dry weight ratio, leukocyte shifts, and levels of cytokines in plasma and lung were evaluated. Budesonide therapy improved the lung function (P/F ratio, oxygenation index, and compliance), decreased the cytokine levels, reduced lung edema and neutrophils influx into the lung, and improved lung architecture in interstitial congestion, hyaline membrane, and atelectasis formation compared to untreated animals. This study indicates that HFOV delivered budesonide effectively ameliorated respiratory function, and attenuated acid-induced lung injury in a rabbit model of severe ARDS.

Department of Physiology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Martin Slovak Republic

Zobrazit více v PubMed

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315:788–800. doi: 10.1001/jama.2016.0291. PubMed DOI

Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H. Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis. 2013;5:326–334. PubMed PMC

Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–2533. doi: 10.1001/jama.2012.5669. PubMed DOI

Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44:725–738. doi: 10.1165/rcmb.2009-0210ST. PubMed DOI PMC

Saguil A, Fargo MV. Acute Respiratory Distress Syndrome: Diagnosis and Management. Am Fam Physician. 2020;101:730–738. PubMed

Boyle AJ, Mac Sweeney R, McAuley DF. Pharmacological treatments in ARDS; a state-of-the-art update. BMC Med. 2013;11:166. doi: 10.1186/1741-7015-11-166. PubMed DOI PMC

Zhang L, Wang Z, Xu F, Ren Y, Wang H, Han D, Lyu J, Yin H. The Role of Glucocorticoids in the Treatment of ARDS: A Multicenter Retrospective Study Based on the eICU Collaborative Research Database. Front Med (Lausanne) 2021;8:678260. doi: 10.3389/fmed.2021.678260. PubMed DOI PMC

Zhao Q, Shi JX, Hu R, Li Q, Zhang CY, Li JS. Effect of glucocorticoids on mortality in patients with acute respiratory distress syndrome: A meta-analysis. Exp Ther Med. 2019;18:4913–4920. doi: 10.3892/etm.2019.8156. PubMed DOI PMC

Donnelly R, Seale JP. Clinical pharmacokinetics of inhaled budesonide. Clin Pharmacokinet. 2001;40:427–440. doi: 10.2165/00003088-200140060-00004. PubMed DOI

Mohamed HS, Meguid MM. Effect of nebulized budesonide on respiratory mechanics and oxygenation in acute lung injury/acute respiratory distress syndrome: Randomized controlled study. Saudi J Anaesth. 2017;11:9–14. doi: 10.4103/1658-354X.197369. PubMed DOI PMC

Murphy KR, Hong JG, Wandalsen G, Larenas-Linnemann D, El Beleidy A, Zaytseva OV, Pedersen SE. Nebulized Inhaled Corticosteroids in Asthma Treatment in Children 5 Years or Younger: A Systematic Review and Global Expert Analysis. J Allergy Clin Immunol Pract. 2020;8:1815–1827. doi: 10.1016/j.jaip.2020.01.042. PubMed DOI

Tripathi S, Saili A. The effect of steroids on the clinical course and outcome of neonates with meconium aspiration syndrome. J Trop Pediatr. 2007;53:8–12. doi: 10.1093/tropej/fml018. PubMed DOI

Festic E, Carr GE, Cartin-Ceba R, Hinds RF, Banner-Goodspeed V, Bansal V, Asuni AT, et al. Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome. Crit Care Med. 2017;45:798–805. doi: 10.1097/CCM.0000000000002284. PubMed DOI PMC

Deliloglu B, Tuzun F, Cengiz MM, Ozkan H, Duman N. Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS. Front Pediatr. 2020;8:210. doi: 10.3389/fped.2020.00210. PubMed DOI PMC

Gao W, Ju N. Budesonide inhalation ameliorates endotoxin-induced lung injury in rabbits. Exp Biol Med (Maywood) 2015;240:1708–1716. doi: 10.1177/1535370215584938. PubMed DOI PMC

Mikolka P, Kopincova J, Kosutova P, Cierny D, Calkovska A, Mokra D. Lung inflammatory and oxidative alterations after exogenous surfactant therapy fortified with budesonide in rabbit model of meconium aspiration syndrome. Physiol Res. 2016;65(Suppl 5):S653–S662. doi: 10.33549/physiolres.933529. PubMed DOI

Mokra D, Kosutova P, Balentova S, Adamkov M, Mikolka P, Mokry J, Antosova M, Calkovska Effects of budesonide on the lung functions, inflammation and apoptosis in a saline-lavage model of acute lung injury. J Physiol Pharmacol. 2016;67:919–932. PubMed

Plaunt AJ, Nguyen TL, Corboz MR, Malinin VS, Cipolla DC. Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery. Pharmaceutics. 2022;14:302. doi: 10.3390/pharmaceutics14020302. PubMed DOI PMC

Meyers M, Rodrigues N, Ari A. High-frequency oscillatory ventilation: A narrative review. Can J Respir Ther. 2019;55:40–46. doi: 10.29390/cjrt-2019-004. PubMed DOI PMC

Ritacca FV, Stewart TE. Clinical review: high-frequency oscillatory ventilation in adults--a review of the literature and practical applications. Crit Care. 2003;7:385–390. doi: 10.1186/cc2182. PubMed DOI PMC

DiBlasi RM, Crotwell DN, Shen S, Zheng J, Fink JB, Yung D. Iloprost drug delivery during infant conventional and high-frequency oscillatory ventilation. Pulm Circ. 2016;6:63–69. doi: 10.1086/685080. PubMed DOI PMC

Alzahrany M, Banerjee A, Salzman G. Flow transport and gas mixing during invasive high frequency oscillatory ventilation. Med Eng Phys. 2014;36:647–658. doi: 10.1016/j.medengphy.2014.01.010. PubMed DOI

Guerin C, Fassier T, Bayle F, Lemasson S, Richard JC. Inhaled bronchodilator administration during mechanical ventilation: how to optimize it, and for which clinical benefit? J Aerosol Med Pulm Drug Deliv. 2008;21:85–96. doi: 10.1089/jamp.2007.0630. PubMed DOI

Ari A, Fink JB. Factors affecting bronchodilator delivery in mechanically ventilated adults. Nurs Crit Care. 2010;15:192–203. doi: 10.1111/j.1478-5153.2010.00395.x. PubMed DOI

Mikolka P, Kosutova P, Kolomaznik M, Mateffy S, Nemcova N, Mokra D, Calkovska A. Efficacy of surfactant therapy of ARDS induced by hydrochloric acid aspiration followed by ventilator-induced lung injury - an animal study. Physiol Res. 2022;71(Suppl 2):S237–S249. doi: 10.33549/physiolres.935003. PubMed DOI PMC

Aggarwal NR, King LS, D’Alessio FR. Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol. 2014;306:L709–L725. doi: 10.1152/ajplung.00341.2013. PubMed DOI PMC

Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18. doi: 10.1038/s41572-019-0069-0. PubMed DOI PMC

Griffiths MJD, McAuley DF, Perkins GD, Barrett N, Blackwood B, Boyle A, Chee N, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019;6:e000420. doi: 10.1136/bmjresp-2019-000420. PubMed DOI PMC

Fujishima S. Guideline-based management of acute respiratory failure and acute respiratory distress syndrome. J Intensive Care. 2023;11:10. doi: 10.1186/s40560-023-00658-3. PubMed DOI PMC

Rettig JS, Smallwood CD, Walsh BK, Rimensberger PC, Bachman TE, Bollen CW, Duval EL, et al. High-Frequency Oscillatory Ventilation in Pediatric Acute Lung Injury: A Multicenter International Experience. Crit Care Med. 2015;43:2660–2667. doi: 10.1097/CCM.0000000000001278. PubMed DOI

Garner SS, Wiest DB, Bradley JW. Albuterol delivery by metered-dose inhaler in a pediatric high-frequency oscillatory ventilation model. Crit Care Med. 2000;28:2086–2089. doi: 10.1097/00003246-200006000-00070. PubMed DOI

Chimenti L, Morales-Quinteros L, Puig F, Camprubi-Rimblas M, Guillamat-Prats R, Gomez MN, Tijero J, et al. Comparison of direct and indirect models of early induced acute lung injury. Intensive Care Med Exp. 2020;8(Suppl 1):62. doi: 10.1186/s40635-020-00350-y. PubMed DOI PMC

Kallet RH. Mechanical Ventilation in ARDS: Quo Vadis? Respir Care. 2022;67:730–749. doi: 10.4187/respcare.09832. PubMed DOI

Kosutova P, Mikolka P, Mokra D, Calkovska A. Anti-inflammatory activity of non-selective PDE inhibitor aminophylline on the lung tissue and respiratory parameters in animal model of ARDS. J Inflamm (Lond) 2023;20:10. doi: 10.1186/s12950-023-00337-y. PubMed DOI PMC

Mikolka P, Kopincova J, Tomcikova Mikusiakova L, Kosutova P, Antosova M, Calkovska A, Mokra D. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury. J Physiol Pharmacol. 2016;67:57–65. PubMed

Liu H, Wang Z, Ren L, Zhang G, Zhao D, Guo Y, Wang L, Feng H. Clinical Efficacy of Budesonide/Glycopyrronium Bromide/Formoterol in the Treatment of Patients with Acute Respiratory Distress Syndrome and Its Effect on Inflammatory Factors. Evid Based Complement Alternat Med. 2022;2022:8150444. doi: 10.1155/2022/8150444. PubMed DOI PMC

Pierrakos C, Karanikolas M, Scolletta S, Karamouzos V, Velissaris D. Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res. 2012;4:7–16. doi: 10.4021/jocmr761w. PubMed DOI PMC

Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet. 2022;400:1145–1156. doi: 10.1016/S0140-6736(22)01485-4. PubMed DOI

Hong S, Jian C, Wang H, Wang X, Xing L, Qiao L. Effects of different doses of methylprednisolone therapy on acute respiratory distress syndrome: results from animal and clinical studies. BMC Pulm Med. 2022;22:348. doi: 10.1186/s12890-022-02148-y. PubMed DOI PMC

Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew A-A, Phoon MC, et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol. 2011;179:199–210. doi: 10.1016/j.ajpath.2011.03.013. PubMed DOI PMC

Mokra D, Mokry J, Drgova A, Petraskova M, Bulikova J, Calkovska A. Intratracheally administered corticosteroids improve lung function in meconium-instilled rabbits. J Physiol Pharmacol. 2007;58(Suppl 5(Pt 1)):389–398. PubMed

Castro CY. ARDS and diffuse alveolar damage: a pathologist’s perspective. Semin Thorac Cardiovasc Surg. 2006;18:13–19. doi: 10.1053/j.semtcvs.2006.02.001. PubMed DOI

Sibbald WJ, Short AK, Warshawski FJ, Cunningham DG, Cheung H. Thermal dye measurements of extravascular lung water in critically ill patients. Intravascular Starling forces and extravascular lung water in the adult respiratory distress syndrome. Chest. 1985;87:585–592. doi: 10.1378/chest.87.5.585. PubMed DOI

Watterberg KL, Clark AR, Kelly HW, Murphy S. Delivery of aerosolized medication to intubated babies. Pediatr Pulmonol. 1991;10:136–141. doi: 10.1002/ppul.1950100217. PubMed DOI

Alzahrany M, Banerjee A. Aerosolized drug delivery in patient-specific lung model during invasive high frequency oscillatory ventilation. J Aerosol Sci. 2015;81:1–20. doi: 10.1016/j.jaerosci.2014.11.005. DOI

Esmaeilizand R, Rocha T, Harrison A, Gray S, Fusch G, Dolovich M, Mukerji A. Efficiency of budesonide delivery via a mesh nebulizer in an in-vitro neonatal ventilator model. Pediatr Pulmonol. 2020;55:2283–2288. doi: 10.1002/ppul.24897. PubMed DOI

Lin CH, Jeng MJ, Yang YC, Hsiao YH, Kou YR. Comparison of different dosing strategies of intratracheally instilled budesonide on meconium injured piglet lungs. Pediatr Pulmonol. 2017;52:891–899. doi: 10.1002/ppul.23697. PubMed DOI

Yu H, Lv M, Zhang S, Zou K, Qian Y, Lv S. Combination therapy with budesonide and acetylcysteine alleviates LPS-induced acute lung injury via the miR-381/NLRP3 molecular axis. PLoS One. 2023;18:e0289818. doi: 10.1371/journal.pone.0289818. PubMed DOI PMC

Dong L, Zhu Y-H, Liu D-X, Li J, Zhao P-C, Zhong Y-P, Chen Y-Q, et al. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice. J Immunol Res. 2019;2019:7264383. doi: 10.1155/2019/7264383. PubMed DOI PMC

Chang X, Li S, Fu Y, Dang H, Liu C. Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data. Respir Res. 2022;23:301. doi: 10.1186/s12931-022-02186-4. PubMed DOI PMC

Mokra D, Mikolka P, Kosutova P, Mokry J. Corticosteroids in Acute Lung Injury: The Dilemma Continues. Int J Mol Sci. 2019;20:4765. doi: 10.3390/ijms20194765. PubMed DOI PMC